Navigation Links
Monkey Study Suggests Long-Term Use of ADHD Drugs Safe
Date:7/19/2012

THURSDAY, July 19 (HealthDay News) -- Long-term use of drugs to treat attention-deficit hyperactivity disorder (ADHD) does not affect brain development or increase the risk of drug abuse, according to a study conducted in monkeys.

Monkeys are good for this type of research because they have relatively long periods of childhood and adolescence that feature hormonal and physical changes much like those that occur in humans, explained the researchers from Wake Forest Baptist Medical Center in Winston-Salem, N.C.

The ages of the 16 juvenile monkeys used in this study were equivalent to 6- to 10-year-old humans. Eight of the monkeys received an extended-release form of the ADHD drug Ritalin for more than a year, which is equivalent to about four years in human children. Eight other monkeys in a control group did not receive any drug treatment.

Imaging scans of all the monkeys' brains were conducted before and after the study, to detect any changes in brain chemistry and structure. The researchers also assessed the monkeys' physical growth.

"After one year of drug therapy, we found no long-lasting effects on the neurochemistry of the brain, no changes in the structure of the developing brain," Linda Porrino, chairwoman of Wake Forest's physiology and pharmacology department, said in a university news release. "There was also no increase in the susceptibility for drug abuse later in adolescence."

"We were very careful to give the drugs in the same doses that would be given to children," she added. "That's one of the great advantages of our study is that it's directly translatable to children."

The study was published online in the July issue of the journal Neuropsychopharmacology.

As many as 5 percent to 7 percent of elementary school children in the United States have been diagnosed with ADHD, which is a behavioral disorder that causes inattention, hyperactivity, impulsivity or a combination of these traits.

Many children with ADHD are prescribed drugs, but little is known about their long-term effects.

"Our study showed that long-term therapeutic use of drugs to treat ADHD does not cause long-term negative effects on the developing brain and, importantly, it doesn't put children at risk for substance abuse later in adolescence," Porrino said.

Although monkeys are similar to humans, the results of this research may not be the same in humans.

More information

The U.S. National Institute of Mental Health has more about attention-deficit hyperactivity disorder.

-- Robert Preidt

SOURCE: Wake Forest Baptist Medical Center, news release, July 18, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers see BPA effects in monkey mammary glands
2. University of Texas Medical Branch to study hospital readmission
3. Fatal Car Crashes Less Likely in Major Cities, CDC Study Finds
4. Study implements community-based approach to treat HIV-infection in rural Uganda
5. Herbal remedy used to treat hepatitis C proves ineffective, Penn study finds
6. Surgery Not Best Option for Early Stage Prostate Cancers: Study
7. Kids Sexual Behavior Influenced by Movie Scenes: Study
8. New study: Elderly Medicare beneficiaries most satisfied with their health insurance
9. Study Gives First Evidence That Adult Human Lungs Can Regrow
10. Study shows colon and rectal tumors constitute a single type of cancer
11. Spouses of severe-sepsis patients at high risk of depression, U-M study shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Monkey Study Suggests Long-Term Use of ADHD Drugs Safe
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: